Evidence map›Paper›PMID 29410668›Full record

ArticleFrontiers in immunology2018

Sulforaphane Inhibits Lipopolysaccharide-Induced Inflammation, Cytotoxicity, Oxidative Stress, and miR-155 Expression and Switches to Mox Phenotype through Activating Extracellular Signal-Regulated Kinase 1/2-Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway in Murine Microglial Cells.

Erden Eren, Kemal Ugur Tufekci, Kamer Burak Isci, Bora Tastan, Kursad Genc, Sermin Genc

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. ERK1/2 activation in anti-inflammatory effects and underlying signaling mechanisms.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Benefits ofInternational journal of molecular sciences · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Erden ErenIzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
Kemal Ugur TufekciIzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
Kamer Burak IsciIzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
Bora TastanIzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
Kursad GencDepartment of Neuroscience, Health Science Institute, Dokuz Eylül University, Izmir, Turkey.
Sermin GencIzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
Dokuz Eylül University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulforaphane (SFN) is a natural product with cytoprotective, anti-inflammatory, and antioxidant effects. In this study, we evaluated the mechanisms of its effects on lipopolysaccharide (LPS)-induced cell death, inflammation, oxidative stress, and polarization in murine microglia. We found that SFN protects N9 microglial cells upon LPS-induced cell death and suppresses LPS-induced levels of secreted pro-inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. SFN is also a potent inducer of redox sensitive transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2), which is responsible for the transcription of antioxidant, cytoprotective, and anti-inflammatory genes. SFN induced translocation of Nrf2 to the nucleus

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidant Response ElementsAntioxidantsApoptosisCell LineCoculture TechniquesCulture Media, ConditionedCytokinesEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansInflammationIsothiocyanatesLipopolysaccharidesMafK Transcription FactorAnti-Inflammatory AgentsAntioxidantsCulture Media, ConditionedCytokinesExtracellular Signal-Regulated MAP KinasesIsothiocyanatesLipopolysaccharidesMafk protein, mouseMafK Transcription FactorMicroRNAsMirn155 microRNA, mouseNfe2l2 protein, mouseNF-E2-Related Factor 2RNA, Small InterferingsulforaphaneSulfoxideslipopolysaccharidemicrogliamiR-155Mox phenotypenuclear factor erythroid 2-related factor 2sulforaphane

Identifiers

PMID29410668
PMCPMC5787131
OpenAlexW2792236624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.